Mexico Point of Care Diagnostics Market Report by Product, Technology, Mode of Prescription, End User, Cities and Companies Analysis 2026-2034

Mexico Point of Care Diagnostics Market Size and Forecast 2026-2034

Mexico Point of Care (POC) Diagnostics Market is expected to experience steady expansion over the forecast period, driven by rising demand for rapid testing, increasing prevalence of infectious diseases, and growing adoption of decentralized healthcare solutions. The market is projected to grow from US$ 710.63 Million in 2025 to US$ 1.46 billion by 2034, registering a Compound Annual Growth Rate (CAGR) of 8.40% from 2026 to 2034. Expanding healthcare infrastructure, technological advancements, and improved accessibility to diagnostic services are further expected to support market growth across Mexico.

Mexico Point of Care Diagnostics Market Overview

Point of Care (POC) diagnostics refers to medical testing performed at or near the site of patient care, rather than in centralized laboratories. These tests provide rapid results, enabling faster clinical decisions, improved patient management, and timely treatment initiation. Common POC diagnostic tools include blood glucose monitors, rapid antigen tests, pregnancy tests, and portable molecular testing devices. Their simplicity, portability, and speed make them highly valuable in emergency settings and remote healthcare environments.

In Mexico, Point of Care diagnostics have gained significant popularity due to the country’s growing healthcare needs and unequal access to advanced laboratory infrastructure, especially in rural and underserved regions. The rising burden of infectious diseases, diabetes, and cardiovascular conditions has further increased demand for quick and reliable testing solutions. Additionally, government initiatives to improve healthcare accessibility, along with private sector investments, have supported adoption. The COVID-19 pandemic also accelerated awareness and usage of rapid diagnostic tools. As a result, POC diagnostics are now becoming an essential component of Mexico’s modern healthcare system, enhancing early detection and improving overall patient outcomes across diverse healthcare settings.

Number and Share of Population Age 65 or Older

Year Population Aged 65+ (Millions) Share of Total Population (%)

1950 1 3.30%

1955 1.1 3.20%

1960 1.3 3.20%

1965 1.6 3.50%

1970 2 3.50%

1975 2.4 3.60%

1980 2.7 3.80%

1985 3 4.00%

1990 3.7 4.60%

1995 4.4 5.00%

2000 5.2 5.50%

2005 5.9 6.00%

2010 7 6.80%

2015 8.3 7.60%

2020 10.2 8.80%

2025 12.6 10.00%

2030 15.4 11.50%

2035 19 13.20%

2040 23 15.30%

2045 27.2 17.40%

2050 31 19.00%

Source: U.S. Census Bureau, International Database (IDB)

People with diabetes, in 1,000s - Mexico

Year People with Diabetes (1,000s) People with Diabetes (Millions)

2000 4,400 4.4

2011 10,300 10.3

2024 13,600 13.6

2050 20,000 20

SOURCE: International Diabetes Federation (IDF)

Recent Developments in Mexico Point of Care Diagnostics Industry

• The Mexican government began its "door-to-door" senior healthcare initiative in 2024, sending medical teams to visit senior citizens in their homes. The program's main goals are to improve vulnerable, frequently immobile people' access to point-of-care services in rural and underserved regions by offering health exams, early illness diagnosis, and basic medical treatment.
• June 2026, Co-Diagnostics, Inc. announced that it has entered into an exclusive distribution agreement with its longstanding partner in Mexico for the Co-Dx™ PCR point-of-care platform*, including the PCR Pro® instrument and associated test kits, advancing the Company's strategy to expand its commercialization network and footprint in Latin America ahead of the platform's market launch, which remains subject to applicable regulatory review and authorization.

Growth Driver in the Mexico Point of Care Diagnostics Market

Increase in Chronic Illnesses

The rising prevalence of chronic diseases in Mexico is a major growth driver for the Point of Care (POC) diagnostics market. Conditions such as diabetes, hypertension, and cardiovascular disorders are becoming increasingly common, placing significant pressure on the national healthcare system and escalating overall treatment costs. According to the National Institute of Statistics and Geography (INEGI), cardiovascular diseases alone accounted for nearly 100,000 deaths in the first half of 2024, surpassing mortality from cancer, COVID-19, and diabetes combined. This growing disease burden has created a strong need for continuous and real-time health monitoring solutions. POC diagnostics play a crucial role by enabling immediate test results that support timely clinical decisions and improve disease management outcomes. Devices such as glucose meters, lipid profile analyzers, and coagulation testing systems are witnessing rising adoption in hospitals and homecare settings. As healthcare shifts toward preventive care and patient self-management, POC technologies are becoming essential tools for reducing hospital readmissions and improving long-term chronic disease control across Mexico.

Government Measures to Improve Disease Surveillance

Government initiatives to strengthen disease surveillance and healthcare accessibility are significantly supporting the growth of the Mexico Point of Care diagnostics market. Following the COVID-19 pandemic, national health authorities have intensified efforts to enhance early detection systems and expand diagnostic infrastructure across both urban and rural regions. Programs such as IMSS-Bienestar are aimed at extending free healthcare coverage to more than 53 million uninsured individuals, improving access to essential medical services. Investments are also being made to upgrade hospitals, complete unfinished healthcare facilities, and deploy mobile and emergency medical teams in underserved areas. Within this framework, POC diagnostic tools are being increasingly integrated into primary and secondary care centers to support rapid testing and real-time disease monitoring. These tools are especially valuable for managing infectious disease outbreaks, improving maternal and child health, and strengthening preventive healthcare strategies. By prioritizing fast, scalable, and decentralized diagnostic solutions, government policies are creating a strong foundation for sustained market expansion.

Increasing Demand for Quick and Remote Testing

The growing demand for rapid and decentralized testing is a key factor driving the expansion of the Point of Care diagnostics market in Mexico. Healthcare disparities between urban and rural populations have created a strong need for accessible diagnostic solutions that do not rely on centralized laboratory infrastructure. POC diagnostics address this challenge by enabling healthcare providers to conduct tests and obtain immediate results directly at the patient’s location, significantly reducing turnaround time and improving treatment efficiency. These solutions are particularly critical in emergency situations and infectious disease outbreaks, where fast diagnosis is essential for effective containment and patient care. In urban healthcare centers, POC testing is increasingly used in emergency departments, outpatient clinics, and private practices to improve workflow efficiency and patient throughput. The rising adoption of mobile clinics and home-based care further supports this trend. As healthcare systems continue to emphasize localized and patient-centric care models, demand for portable and rapid diagnostic technologies is expected to grow steadily across Mexico.

Challenges in the Mexico Point of Care Diagnostics Market

Lack of Awareness and Education

A key challenge limiting the growth of the Point of Care diagnostics market in Mexico is the insufficient awareness and understanding of these technologies among both healthcare professionals and patients. In many regions, particularly rural and underserved areas, medical practitioners may not be fully informed about the latest advancements in POC diagnostic tools or their benefits in improving diagnostic speed and clinical decision-making. This lack of knowledge often leads to slow adoption in healthcare facilities. Similarly, patients who are unaware of the availability and advantages of POC testing are less likely to request or utilize such services, further restricting market penetration. Misconceptions regarding accuracy, reliability, and usability also contribute to hesitation in adoption. To address this challenge, structured awareness campaigns and educational initiatives are necessary to highlight the importance of rapid diagnostics in improving healthcare outcomes. Strengthening communication between healthcare providers, institutions, and patients will be essential to increasing acceptance and encouraging broader integration of POC diagnostics into routine medical practice.

Limited Training for Healthcare Providers

The limited availability of proper training for healthcare professionals represents another significant barrier to the widespread adoption of Point of Care diagnostics in Mexico. Although POC diagnostic devices are designed to simplify testing and deliver rapid results, accurate usage still requires proper technical knowledge and interpretation skills. In many healthcare facilities, especially in rural and resource-constrained regions, medical staff may not receive adequate training on operating these devices or understanding test outcomes. This skill gap can lead to incorrect diagnoses, delayed treatment decisions, and reduced confidence in POC technologies. As a result, the overall effectiveness of these diagnostic tools may be compromised. To overcome this challenge, there is a strong need for comprehensive training programs, workshops, and continuous professional development initiatives for healthcare workers. Strengthening technical competency will ensure accurate test performance and interpretation, ultimately improving patient care quality. Enhanced training efforts will also support better integration of POC diagnostics into everyday clinical workflows across Mexico’s healthcare system.

Mexico Glucose Monitoring Kits Market

Mexico Glucose Monitoring Kits Market is witnessing strong growth due to the increasing prevalence of diabetes across the country. A growing number of patients require continuous blood glucose tracking to manage lifestyle-related and chronic metabolic disorders. Urbanization, sedentary habits, and unhealthy dietary patterns have significantly contributed to rising diabetes cases. As a result, demand for home-based glucose monitoring kits and portable glucometers has increased. These devices enable patients to track sugar levels in real time, allowing timely insulin adjustment and reducing complications. Hospitals and clinics are also encouraging self-monitoring practices, further boosting adoption. Technological advancements such as digital glucose meters and smartphone-connected devices are enhancing user convenience and accuracy. Overall, the growing diabetic population is a key factor driving sustained market expansion in Mexico.

Mexico Lateral Flow Point of Care Diagnostics Market

Mexico Lateral Flow Point of Care Diagnostics Market is growing rapidly due to increasing demand for quick and cost-effective diagnostic solutions. Lateral flow tests are widely used for detecting infectious diseases, pregnancy, and other medical conditions due to their simplicity and fast results. Healthcare facilities in Mexico are increasingly adopting these tests in emergency rooms, clinics, and remote healthcare centers. Their ability to provide results within minutes without complex laboratory equipment makes them highly suitable for resource-limited settings. The COVID-19 pandemic further accelerated awareness and usage of rapid antigen tests, strengthening market penetration. Additionally, government health programs and private sector investments are promoting decentralized testing solutions. With rising focus on early disease detection and outbreak control, lateral flow diagnostics continue to gain strong traction across Mexico’s healthcare system.

Mexico Prescription-Based Point of Care Diagnostics Device Market

Mexico Prescription-Based Point of Care Diagnostics Device Market is expanding due to the increasing integration of advanced diagnostic devices within clinical practice. These devices are typically prescribed by healthcare professionals for accurate monitoring of chronic diseases and critical conditions. Hospitals and specialized clinics are adopting prescription-based POC tools for conditions such as cardiovascular diseases, diabetes, and coagulation disorders. These systems offer high accuracy, reliability, and regulatory compliance, making them essential for professional healthcare environments. Growing physician awareness about advanced diagnostic technologies is further supporting adoption. Additionally, improvements in healthcare infrastructure and insurance coverage are making these devices more accessible to patients. As demand for precision diagnostics rises, prescription-based POC devices are becoming an important part of Mexico’s modern medical ecosystem.

Mexico Point of Care Diagnostics Home Care Market

Mexico Point of Care Diagnostics Home Care Market is growing significantly due to the shift toward patient-centric and home-based healthcare services. Increasing elderly population and rising incidence of chronic diseases are encouraging patients to manage their health from home. Home-use POC devices such as glucose monitors, pregnancy kits, and blood pressure testing devices are gaining popularity due to convenience and affordability. These tools reduce the need for frequent hospital visits, lowering healthcare costs and improving patient comfort. Technological advancements such as mobile app integration and smart monitoring systems are further enhancing home diagnostic capabilities. Healthcare providers are also promoting remote monitoring to improve treatment adherence and early intervention. Overall, the growing preference for home-based care solutions is a major factor driving expansion of the POC diagnostics home care segment in Mexico.

Market Segmentations

Product

• Glucose Monitoring Kits
• Infectious Diseases Kits
• Pregnancy & Fertility Testing Kits
• Hematology Testing Kits
• Cardiometabolic Monitoring Kits
• Urinalysis Testing Kits
• Cholesterol Test Strips
• Drugs Abuses Testing Kits
• Others

Technology

• Lateral Flow
• Agglutination
• Flow Through
• Solid phase
• Biosensor
• Others

Mode of Prescription

• Prescription-Based Devices
• Over-the-counter (OTC)-Based Devices

End Users

• Professional Diagnostic Centers
• Research Laboratories
• Home Care
• Others

Cities

• Tijuana
• Ecatepec
• León
• Puebla
• Ciudad Juárez
• Guadalajara
• Monterrey
• Nezahualcóyotl
• Zapopan

All companies have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue

Key Players Analysis

• Sysmex
• Abbott Laboratories
• Becton Dickinson and Company
• Danaher Corporation
• Quidel Diagnostics
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc.